about
Gonadotrophins for ovulation induction in women with polycystic ovarian syndromeIncreased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndromeOnset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirlsReproductive function in female rats submitted to chronic hypobaric hypoxia.Is valproate pharmacotherapy associated with polycystic ovaries?Polycystic ovarian disease.Unwanted hairPrevalence of polycystic ovaries in women with anovulation and idiopathic hirsutismPolycystic ovarian syndrome in women with epilepsy: a review.Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.The influence of obesity on hyperandrogenism and infertility in the female.Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism.Colocalization of FM1-43, Bassoon, and GnRH-1: GnRH-1 release from cell bodies and their neuroprocesses.Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Infertility in WNIN Obese Mutant Rats-Causes?Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.The treatment of patients with polycystic ovaries undergoing IVF.The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatmentObesity and the role of gut and adipose hormones in female reproduction.Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease.Polycystic ovaries in childhood.Neuroendocrine dysfunction in PCOS: a critique of recent reviews.Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro.Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.The estrogen-injected female mouse: new insight into the etiology of PCOS.Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Relationship between serum cystatin C and polycystic ovary syndrome.Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.Role of female pelvic anatomy in infertility.Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Clinical applications of GnRH analogs.Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study.Polycystic ovaries and polycystic ovary syndrome.Polycystic ovary syndrome--long-term metabolic consequences.LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.Genetic and non-genetic theories on the etiology of polycystic ovary syndrome.
P2860
Q24187261-190B3BF8-B33E-4E13-94CA-7632111341A5Q24654143-BF0B8911-2A37-4295-86E2-4479DF6CDA76Q24674618-730FC019-DF1C-4128-B45F-D4CA070031F9Q33427062-D313ED55-7EE4-46FC-8EEA-C5FC13DC14C1Q33779880-28A4EF5A-196A-496B-BE36-653CA6B3EF60Q34192098-6E13F0CE-C984-40A1-81D5-CEA7D86C019FQ34287538-1CF46E06-1544-4ABA-9A6C-24250100421DQ34287561-812F6BAA-CACF-47D9-9352-435528EA74FDQ34345051-5430A836-F2B1-4254-B546-45D309439B7DQ34354008-20FB9E56-9639-42A6-AAB6-B512144905ACQ34742759-66863924-98DC-47A2-9028-4378070AFEFCQ35008634-6836AF2B-1C59-4CC2-9B0B-8D6F9DBCDA90Q35417284-2E8A3032-F17E-4FC9-ABE3-A6567B037DADQ35606054-A5284A15-4988-40A3-9FF4-F68D26A745F4Q35684706-994D4591-037D-47BA-9774-FC8BFD6BAE64Q35890067-FB3A5539-3184-4B7F-B347-F286E23677D2Q36267404-6C98C20C-6FF6-4712-8F4B-3F269089F7F5Q36269492-4401ABB9-0E46-4371-81F5-D767DAFE4591Q36507088-61492B00-1C54-43F8-9DBF-6BD60456E346Q36732717-F090C950-04B4-47A7-B4B0-3927F1C40F29Q36760908-EE95EEB1-EF22-458C-A62E-2CD93AA3786BQ36897000-15D0B3EF-657F-4637-B34F-8C8445B08E91Q36948002-8EEA816A-5C39-4C14-8D98-DA7A23ED8C40Q37035425-64A4FA7A-6A7D-40BF-8DDD-A1AA796952F8Q37060111-05358707-CEBE-490C-9B39-212ADB3F4E31Q37129643-7F45652C-047D-4AE6-97DF-96C885758948Q37225020-445CB853-0B6A-4768-BB15-547685E1AEEFQ37469965-9AB6933C-0D31-42E2-95E9-2D6967771C89Q37570577-664AA4C6-BA3A-4D29-9060-BD7B16D23FD5Q37615466-6E246B16-AEFD-488E-A07A-18375EF2E894Q37771103-CDE792C0-E306-4891-8A2B-E9316527D3A6Q38063831-F5F467A9-E004-493D-905D-CC9492E48BF4Q38351124-8CDAF276-2D2A-4127-8A76-E7DD68F30A03Q39001136-4DA8C4A3-9A4B-4B54-B4CE-E686F4FAC239Q39564626-B3629CFD-7C05-46D0-B190-22192E7415A7Q39593199-3BD3C180-C6DD-4B38-932D-91D724CE0EB7Q39703582-4B2F7D7F-09BE-4AE8-B7EF-695A6565C5DFQ40621362-0FF087B1-A971-4D7A-944F-31FDB2BB6D04Q41193834-807B4D8C-07B5-4D55-A5E9-0601518C5815Q41208607-84A6EE84-B498-441F-B762-C4346C086B2B
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
The polycystic ovary syndrome.
@en
type
label
The polycystic ovary syndrome.
@en
prefLabel
The polycystic ovary syndrome.
@en
P2860
P1476
The polycystic ovary syndrome.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2265.1980.TB02132.X
P577
1980-02-01T00:00:00Z